122261 SS LegalNotice Illumina Sequencer ELS.docx
DOCX document 60 KB Posted
- Attached to
- Gene Sequencing Equipment
- Solicitation number
- L124454
- Issued by
- Adams County, Asotin County, Benton County, Chelan County, Clallam County, Clark County, Columbia County, Cowlitz County, Douglas County, Ferry County, Franklin County, Garfield County, Grant County, Grays Harbor County, Island County, Jefferson County, King County, Kitsap County, Kittitas County, Klickitat County, Lewis County, Lincoln County, Mason County, Okanogan County, Pacific County, Pend Oreille County, Pierce County, San Juan County, Skagit County, Skamania County, Snohomish County, Spokane County, Stevens County, Thurston County, Wahkiakum County, Walla Walla County, Whatcom County, Whitman County, Yakima County, Asotin City, Clarkston City, Clarkston Heights-Vineland CDP, West Clarkston-Highland CDP, Benton City, Chelan City, Chelan Falls CDP, Clallam Bay CDP, Lewisville CDP, Rock Island City, Pacific Beach CDP, Whidbey Island Station CDP, Mercer Island City, Pacific City, Bainbridge Island City, Kingston CDP, Kitsap Lake CDP, Kittitas City, Klickitat CDP, Okanogan City, Anderson Island CDP, Fort Lewis CDP, Fox Island CDP, Herron Island CDP, Ketron Island CDP, North Fort Lewis CDP, Raft Island CDP, Stevenson City, Hat Island CDP, Lake Stevens City, Snohomish City, Spokane City, Spokane Valley City, Puget Island CDP, Garfield Town, Yakima City, Washington
About this file
This document is a Sole Source Posting from the Washington State Department of Health announcing their intent to award a sole source purchase order to Illumina, Inc. to procure a MiniSeq whole genome sequencing instrument. The Department of Health requires this sole source purchase to provide increased sequencing capacity on an instrument platform already validated and in use at their Public Health Laboratories. The purchase order will be issued on or after March 29, 2024 at a cost of $63,159.11.
The document outlines the specific technical capabilities required for the next generation sequencing instrument, including the use of sequencing by synthesis (SBS) technology, flow cell technology, cluster generation, and fluorescence detection. The Department of Health is posting this sole source notice per the state's procurement policies, and is seeking capability statements from any other qualified sources within 5 working days of the announcement. In the absence of other qualified sources, the Department intends to proceed with the sole source purchase from Illumina.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 4588983_Washington State Department Of Health.pdf | ||
| L124454 Illumina.pdf | ||
| Illumina MiniSeq SoleSourceJustification.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
STATE OF WASHINGTON
Department of Enterprise Services
SOLE SOURCE POSTING
March 19, 2024
The Washington State Department of Health contemplates awarding a sole source purchase order to Illumina, Inc. to procure a MiniSeq™ whole genome sequencing instrument:
The Washington State Department of Health requires this sole source purchase because we need an additional instrument to provide increased sequencing capacity, on the same testing platform already validated and in use at our Public Health Laboratories.
The Washington State Department of Health will enter into a onetime purchase order with Illumina, Inc. The purchase order will be issued on or after March 29th, 2024. The cost of this purchase order is $63,159.11.
Offerors contemplating the above requirements are required to submit capability statements detailing their ability to meet the state’s requirements within five (5) working days of this announcement. Note that the technology sequencing by synthesis (SBS) is a patented process, and that procuring these instruments ensures compatibility with existing DOH equipment and workflows in the laboratory.
Capability statements should address the following state requirements:
· Capable of manufacturing a next generation sequencing instrument that employs a flow cell and the technology of cluster generation utilizing oligonucleotides bound to a synthetic platform capable of capturing indexes ligated onto prepared templates,
· Capable of manufacturing a next generation sequencing instrument that amplifies the captured through a process of repeated bridge amplification cycles utilizing appropriate buffers cycled through the flow cell,
· Capable of manufacturing patented technology which provides a next generation sequencing instrument that employs sequencing by synthesis (SBS), a method lacking the traditional polymerase driven synthesis,
· Capable of manufacturing a next generation sequencing instrument that can detect emitted fluorescence generated from incorporated nucleotides during the SBS cycle, and
· Capable of manufacturing a next generation sequencing instrument that can track fluorescent signals from all collated clusters throughout the sequencing cycles and generate files that contain false data of the compiled sequence run as well as sequencing run metrics for quality assurance.
In the absence of other qualified sources, it is the state’s intent to make a sole source purchase. To submit capability statements or for questions, contact:
Name: Matt Hanson Email: Matt.Hanson@doh.wa.gov and cc: bids@doh.wa.gov
NOTE: DOH is posting this sole source notice per DES Policy 140-00. This notice is made available on the DOH web site and via WEBS under commodity codes: 938-63 Laboratory Equipment & Accessories: Specialized, Biochemistry, Biology, Chemistry, etc, Maintenance & Repair; 493-08 Biochemical Research Equipment: DNA Synthesizers, Enzyme Analyzers, Respirometers, Revised: 7-12-22 image1.png
File details come from the government source that posted it. Updated .